ABMD Financial Facts
Funded research and development: 27KResearch and development: 18.05M
See Full Income Statement
Total assets: 474.9M
Other long-term liabilities: 4K
See Full Balance Sheet
Abiomed Inc. (ABMD) Earnings
|
Expand Research on ABMD
| Next EPS Date | N/A | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +11.0% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +1.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/4/10  |
 |
Q211 | -$0.05 | -$0.14 | +$0.09 | N/A | N/A | = |  | | Details |
| 8/1/13 |
|
Q114 | -$0.04 | $0.06 | -$0.10 | $42.7M | $42.93M |  |
| | Details |
| 7/31/14 |
|
Q115 | -$0.04 | N/A | N/A | $48.8M | $297.1M | |
| | Details |
| 8/4/11 |
|
Q112 | -$0.03 | -$0.06 | +$0.03 | $27.4M | $27.79M | |
| | Details |
| 8/5/21 |
|
Q122 | N/A | $1.05 | N/A | N/A | $240.91M | |
N/A | N/A | |
| 2/2/23 | Q323 | N/A | $1.18 | N/A | N/A | $290.55M | = | N/A | N/A | ||
| 5/18/11 |
|
Q411 | $0.01 | -$0.04 | +$0.05 | $28.5M | $27.71M | |
| | Details |
| 2/3/11 |
|
Q311 | $0.02 | -$0.09 | +$0.11 | $27.2M | $24.33M | = | | | Details |
